Clinical Trial Update: A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating circulating tumor DNA (ctDNA) testing in people with diffuse large B-cell lymphoma and related high-grade B-cell lymphomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Diffuse Large B-cell Lymphoma of the Breast
• Diffuse Large B-cell Lymphoma of the Testis
• High-grade B-cell Lymphoma
• Hiv-associated Diffuse Large B-cell Lymphoma
• Intravascular Large B-cell Lymphoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma | Phase 2 | Status: RECRUITING